Nathan J. Dowden
President and Chief Operating Officer
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Entrada Therapeutics, Inc. (TRDA) | President and Chief Operating Officer | $499,200 | $2,223,497 |
| 2024 | Entrada Therapeutics, Inc. (TRDA) | President and Chief Operating Officer | $480,000 | $2,460,688 |
| 2023 | Entrada Therapeutics, Inc. (TRDA) | President and Chief Operating Officer | $456,501 | $1,485,455 |
| 2022 | Entrada Therapeutics, Inc. (TRDA) | President and Chief Operating Officer | $440,000 | $1,540,389 |
| 2021 | Entrada Therapeutics, Inc. (TRDA) | Chief Operating Officer | $378,532 | $2,312,017 |
| 2020 | Entrada Therapeutics, Inc. (TRDA) | Chief Operating Officer | $354,488 | $561,497 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.